Patient and Stakeholder Engagement

Strategic Start-Up: Project Managers Addressing MAGI Conference in Las Vegas

DURHAM, N.C., OCTOBER 3, 2016 — You’re starting a lengthy project that’s fraught with risk and could cost a billion dollars or more to complete. A couple of early missteps might spell disaster. Welcome to clinical drug research.

Boost your odds of success with a robust project schedule and carefully executed startup plan. At MAGI’s Clinical Research Conference 2016 West in Las Vegas. Premier Research senior project manager Robin Farrar-Snidow will present Setting and Managing Priorities in a Clinical Project Schedule at 10:30 a.m. Monday, October 24.

Considering the enormous time and expense involved in drug development, you can’t leave planning to chance. And what occurs at startup affects everything that happens next: things like budgeting, picking the team, creating timelines, selecting sites, and enrolling patients. Spend 45 minutes with us and start your next drug development effort on the right foot.

Later that day at MAGI, Premier Research will participate in a project management panel discussion. Senior project manager Tosha Doornek will join other industry consultants at 3:45 p.m. for a session titled Growing Strong & Healthy Clinical Project Managers.

About Premier Research

Premier Research is a leading clinical development service provider that helps highly innovative biotech, medical device, and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, medical devices, neuroscience, oncology, pediatrics and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.